Correlation Between InMed Pharmaceuticals and Satsuma Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both InMed Pharmaceuticals and Satsuma Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining InMed Pharmaceuticals and Satsuma Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between InMed Pharmaceuticals and Satsuma Pharmaceuticals, you can compare the effects of market volatilities on InMed Pharmaceuticals and Satsuma Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in InMed Pharmaceuticals with a short position of Satsuma Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of InMed Pharmaceuticals and Satsuma Pharmaceuticals.

Diversification Opportunities for InMed Pharmaceuticals and Satsuma Pharmaceuticals

-0.32

Correlation Coefficient

InMed Pharmaceuticals  Satsuma Pharmaceuticals

Very good diversification

The 3 months correlation between InMed and Satsuma is -0.32. Overlapping area represents the amount of risk that can be diversified away by holding InMed Pharmaceuticals and Satsuma Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Satsuma Pharmaceuticals and InMed Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on InMed Pharmaceuticals are associated (or correlated) with Satsuma Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Satsuma Pharmaceuticals has no effect on the direction of InMed Pharmaceuticals i.e., InMed Pharmaceuticals and Satsuma Pharmaceuticals go up and down completely randomly.

Pair Corralation between InMed Pharmaceuticals and Satsuma Pharmaceuticals

If you would invest  110.00  in Satsuma Pharmaceuticals on September 23, 2024 and sell it today you would earn a total of  0.00  from holding Satsuma Pharmaceuticals or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	4.76%
Values	Daily Returns

InMed Pharmaceuticals  vs.  Satsuma Pharmaceuticals

InMed Pharmaceuticals

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in InMed Pharmaceuticals are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of very unsteady basic indicators, InMed Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Satsuma Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Satsuma Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Satsuma Pharmaceuticals is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with InMed Pharmaceuticals and Satsuma Pharmaceuticals

The main advantage of trading using opposite InMed Pharmaceuticals and Satsuma Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if InMed Pharmaceuticals position performs unexpectedly, Satsuma Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Satsuma Pharmaceuticals will offset losses from the drop in Satsuma Pharmaceuticals' long position.

The idea behind InMed Pharmaceuticals and Satsuma Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.